Importantly, we showed for the first time that the impact of PTGR2 on cancer cell death seemed to be the resultant of a defective antioxidative defense system involving xCT and CTH, both of which are important regulators of intracellular reduced GSH. This evidence concerns the gene PTGR2 and cancer.